Peer-reviewed veterinary case report
Hereditary Equine Regional Dermal Asthenia homozygote adult working horse with mild signs - A Case Report.
- Journal:
- Journal of equine veterinary science
- Year:
- 2021
- Authors:
- Patterson Rosa, Laura et al.
- Affiliation:
- Etalon
- Species:
- horse
Plain-English summary
This case report discusses a condition called Hereditary Equine Regional Dermal Asthenia (HERDA), which affects American Quarter Horses and some related breeds. HERDA is caused by a genetic mutation and leads to very fragile skin that doesn't heal well, often resulting in painful wounds. In this report, an 8-year-old horse showed mild signs of the condition, including skin lesions under the saddle area, which prompted the owners to seek genetic testing. The tests confirmed that the horse had the genetic mutation associated with HERDA. Unfortunately, there is no treatment for this condition, and horses with more severe symptoms are often considered unrideable.
Abstract
Hereditary Equine Regional Dermal Asthenia (HERDA) is an autosomal recessive condition present in the American Quarter Horse and other related breeds. Resulting from a mutation in the peptidyl-prolyl cis-trans isomerase B (PPIB) gene, HERDA is homologous to Ehlers-Danlos syndrome in humans. Characterized by fragile, hyperelastic, skin, HERDA affected horses often present first with slow-healing wounds usually on the dorsum, and resulting in atrophic scars, seromas, and ulcers. As there is no treatment for the condition affected horses are typically reported to be unrideable, and if persistent wounds are sufficiently severe, may require euthanasia. This case report describes clinical presentation and genetic diagnostics of HERDA in an 8-year-old horse with notably mild clinical signs, previously undiagnosed. On recommendation from the referring veterinarian, the horse owners pursued genetic diagnostics for HERDA following development of painful dorsal skin lesions under the saddle area during a riding clinic. The individual was confirmed homozygous for HERDA c.115G>A missense mutation in the PPIB gene by commercial testing service (Etalon Diagnostics Inc.). Further objective studies on the severity and clinical presentation of HERDA are necessary to evaluate complex elements of this disease. Furthermore, mildly affected individuals may be underdiagnosed as a result of not demonstrating the clinical signs that commonly encourage genetic testing.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication: https://pubmed.ncbi.nlm.nih.gov/34670706/